Analyst Reco. Invitae Corporation

Equities

NVTA.Q

US46185L1035

End-of-day quote OTC Markets Other stock markets 03:30:00 26/04/2024 am IST			5-day change	1st Jan Change
0.0005 ^USD	-94.44%		-66.67%	-99.92%

25/04	Labcorp beats quarterly estimates on strong testing demand	RE
25/04	Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln	RE

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Goldman Sachs Adjusts Price Target on Invitae to $0.50 From $1, Maintains Sell Rating	20/23/20	MT
Piper Sandler Trims Invitae Price Target to $0.50 From $1.50, Maintains Underweight Rating	15/23/15	MT
Goldman Sachs Adjusts Price Target on Invitae to $1 From $1.50, Maintains Sell Rating	21/23/21	MT
Piper Sandler Cuts Invitae's Price Target to $1.50 From $1.75, Maintains Underweight Rating	15/23/15	MT
Raymond James Downgrades Invitae to Underperform From Market Perform	15/23/15	MT
Piper Sandler Adjusts Invitae's Price Target to $1.75 From $2.25, Keeps Underweight Rating	03/23/03	MT
Goldman Sachs Downgrades Invitae to Sell From Neutral With $2 Price Target	31/23/31	MT
Credit Suisse Initiates Coverage of 20 Companies in Life Science Tools, Services, Diagnostics Sectors; Outperform-Rated Bio-Rad, IQVIA, Bipo-Techne, Natera Named Top Picks	25/22/25	MT
JPMorgan Downgrades Invitae to Underweight From Neutral	10/22/10	MT
Cowen Downgrades Invitae to Market Perform From Outperform, Adjusts Price Target to $2.50 From $8	26/22/26	MT
Raymond James Downgrades Invitae to Market Perform From Outperform	21/22/21	MT
Goldman Sachs Further Lowers Price Target for Invitae to $4 From $6, Maintains Neutral Rating	19/22/19	MT
Cowen Lowers Invitae's Price Target to $8 From $10, Maintains Outperform Rating	19/22/19	MT
SVB Securities Downgrades Invitae to Market Perform From Outperform, Adjusts Price Target to $2 From $8	19/22/19	MT
Benchmark Downgrades Invitae to Hold From Buy	19/22/19	MT
Goldman Sachs Adjusts Price Target for Invitae to $6 From $7, Maintains Neutral Rating	18/22/18	MT
Benchmark Adjusts Invitae's Price Target to $6 From $13, Reiterates Buy Rating	13/22/13	MT
Piper Sandler Starts Invitae at Underweight With $2.50 Price Target	03/22/03	MT
Raymond James Adjusts Invitae's Price Target to $8.50 From $10.50, Keeps Outperform Rating	05/22/05	MT
Raymond James Adjusts Invitae's Price Target to $10.50 From $15, Keeps Outperform Rating	18/22/18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Invitae Corporation

Equities

NVTA.Q

US46185L1035

Analyst Reco.

Filters